These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND LDH AND Prognosis
54 results:

  • 1. The Chemokine CXCL7 is Correlated with ldh-A and Predicts the prognosis of Patients with colorectal cancer.
    Liang H; Li L; Huang B; Cheng G; Ao J; Hao S
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):166. PubMed ID: 38682188
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. NR4A1 depletion inhibits colorectal cancer progression by promoting necroptosis via the RIG-I-like receptor pathway.
    Zhu J; Li J; Yang K; Chen Y; Wang J; He Y; Shen K; Wang K; Shi T; Chen W
    Cancer Lett; 2024 Mar; 585():216693. PubMed ID: 38301909
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma.
    Cao K; Zhu J; Lu M; Zhang J; Yang Y; Ling X; Zhang L; Qi C; Wei S; Zhang Y; Ma J
    EBioMedicine; 2024 Jan; 99():104920. PubMed ID: 38101299
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluating Prognostic Value of Dynamics of Circulating Lactate Dehydrogenase in colorectal cancer Using Modeling and Machine Learning.
    Ding H; Yuan M; Yang Y; Gupta M; Xu XS
    Clin Pharmacol Ther; 2024 Apr; 115(4):805-814. PubMed ID: 37724436
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis.
    Huang Y; Yang W; Yang L; Wang T; Li C; Yu J; Zhang P; Yin Y; Li R; Tao K
    Sci Rep; 2023 Sep; 13(1):14359. PubMed ID: 37658132
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The colon inflammatory index score can predict the survival outcome after resection of colorectal cancer: a retrospective multicentre study.
    Akiyama T; Miyamoto Y; Matsuda A; Tokunaga R; Ogawa K; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Sonoda H; Yamada T; Yoshida H; Baba H
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7887-7894. PubMed ID: 37058251
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Carcinoembryonic antigen kinetics predict response to first-line treatment in metastatic colorectal cancer: Analysis from PRODIGE 9 trial.
    Salfati D; Huot M; Aparicio T; Lepage C; Taieb J; Bouché O; Boige V; Phelip JM; Dahan L; Bennouna J; Le Malicot K; Boussari O; Gornet JM
    Dig Liver Dis; 2023 Jun; 55(6):791-798. PubMed ID: 36725401
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic cancer: A Propensity Score Matching Analysis.
    Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
    Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
    [TBL] [Abstract] [Full Text] [Related]  

  • 9.
    Wijler LA; Dijk FJ; Quirindongo H; Raats DAE; Dorresteijn B; Furber MJW; May AM; Kranenburg O; van Dijk M
    Oncotarget; 2022 Oct; 13():1094-1108. PubMed ID: 36242541
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Significance of the preoperative lactate dehydrogenase/albumin Ratio in the prognosis of Colon cancer: a retrospective study.
    Xie Z; Zhou H; Wang L; Wu Y
    PeerJ; 2022; 10():e13091. PubMed ID: 35295561
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Changes in serum lactate dehydrogenase levels as markers of pathological response and prognosis in colorectal liver metastases patients receiving neoadjuvant chemotherapy followed by resection.
    Chen J; Chen Q; Yao J; Jiang Y; Zhou J; Zhao H; Cai J
    Ann Palliat Med; 2021 Oct; 10(10):10276-10292. PubMed ID: 34551571
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nomograms predicting primary lymph node metastases and prognosis for synchronous colorectal liver metastasis with simultaneous resection of colorectal cancer and liver metastases.
    Yao J; Chen Q; Deng Y; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Zhao H; Cai J
    Ann Palliat Med; 2021 Apr; 10(4):4220-4231. PubMed ID: 33832313
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Contrast-Enhanced CT-based Textural Parameters as Potential Prognostic Factors of Survival for colorectal cancer Patients Receiving Targeted Therapy.
    Zhao Y; Yang J; Luo M; Yang Y; Guo X; Zhang T; Hao J; Yao Y; Ma X
    Mol Imaging Biol; 2021 Jun; 23(3):427-435. PubMed ID: 33108800
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma.
    Zhao F; Qin Y; Yang J; Liu P; He X; Zhou L; Zhou S; Gui L; Zhang H; Wang X; Jiang S; Zhong Q; Zhou Y; Shi Y
    Asia Pac J Clin Oncol; 2020 Dec; 16(6):385-391. PubMed ID: 32779387
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism.
    Ruhnau J; Parczyk J; Danker K; Eickholt B; Klein A
    BMC Cancer; 2020 Jul; 20(1):617. PubMed ID: 32615946
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer.
    Lisanti C; Basile D; Parnofiello A; Bertoli E; Andreotti VJ; Garattini SK; Bartoletti M; Cattaneo M; Di Nardo P; Bonotto M; Casagrande M; Da Ros L; Cinausero M; Foltran L; Pella N; Buonadonna A; Aprile G; Fasola G; Puglisi F
    J Geriatr Oncol; 2020 Nov; 11(8):1268-1273. PubMed ID: 32576519
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic colorectal cancer.
    Basile D; Garattini SK; Corvaja C; Montico M; Cortiula F; Pelizzari G; Gerratana L; Audisio M; Lisanti C; Fanotto V; Ongaro E; Iacono D; Cardellino GG; Foltran L; Pella N; Buonadonna A; Aprile G; Di Maio M; Fasola G; Puglisi F
    Oncologist; 2020 Aug; 25(8):661-668. PubMed ID: 32202020
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. What can preoperative blood tests tell us about colorectal cancer?
    Kostakis ID; Vaiopoulos AG; Garoufalia Z; Papavassiliou AG; Kykalos S; Kouraklis G; Tsourouflis G
    J BUON; 2018 Dec; 23(7):84-95. PubMed ID: 30722116
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic Significance of Serum Lactic Acid, Lactate Dehydrogenase, and Albumin Levels in Patients with Metastatic colorectal cancer.
    Wei Y; Xu H; Dai J; Peng J; Wang W; Xia L; Zhou F
    Biomed Res Int; 2018; 2018():1804086. PubMed ID: 30627541
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The association between markers of tumour cell metabolism, the tumour microenvironment and outcomes in patients with colorectal cancer.
    Roseweir AK; Clark J; McSorley ST; vanWyk HC; Quinn JA; Horgan PG; McMillan DC; Park JH; Edwards J
    Int J Cancer; 2019 May; 144(9):2320-2329. PubMed ID: 30521130
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 3.